Business Context and Reporting Period
This Form 8-K filing by Palisade Bio, Inc. (PALI) reports on events occurring on September 18, 2025. The Company is a Delaware corporation with its principal executive offices in Carlsbad, California, and its common stock trades on the Nasdaq Capital Market.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance events regarding a stockholder meeting.
Material Changes and Events
- Adjournment of Special Meeting: On September 18, 2025, the Company convened a special meeting of stockholders but adjourned it without conducting business.
- Reason for Adjournment: A quorum was not achieved due to an insufficient number of shares present in person or represented by proxy.
- Rescheduled Date: The adjourned meeting is set to reconvene on Friday, September 26, 2025, at 10:00 a.m. Pacific Time.
- Record Date: The record date for determining voting eligibility remains July 28, 2025.
- Proposals: No changes have been made to the proposals to be voted upon.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management commentary on operational outlook, or specific risk factors beyond the immediate contingency of the failed quorum. Stockholders who have already voted are not required to take further action unless they wish to change their vote. Voting instructions remain available via the definitive proxy statement filed on August 18, 2025.
Key Facts for Investor Verification
- Verify the specific proposals to be voted on at the reconvened meeting on September 26, 2025, by reviewing the Schedule 14A proxy statement.
- Confirm whether the Company expects to achieve a quorum at the rescheduled date given the initial failure.
- Check for any subsequent filings regarding the outcome of the September 26, 2025 meeting.